NuVasive Inc. (NUVA)

52.58
0.57 1.10
NASDAQ : Health Technology
Prev Close 53.15
Open 53.65
Day Low/High 52.14 / 54.23
52 Wk Low/High 44.62 / 72.41
Volume 501.80K
Avg Volume 635.40K
Exchange NASDAQ
Shares Outstanding 51.42M
Market Cap 2.89B
EPS 1.60
P/E Ratio 114.83
Div & Yield N.A. (N.A)

Latest News

Biglari Holdings Doesn’t Look Appetizing, Plus 4 Other Good Short Candidates

BH, ENLK, R, DVN and NUVA were all recently downgraded by TheStreet’s Quant Ratings service.

NuVasive's Proprietary Porous PEEK™ Implant To Be Used In Flagship XLIF® Procedure

NuVasive's Proprietary Porous PEEK™ Implant To Be Used In Flagship XLIF® Procedure

Company receives FDA 510(k) clearance for use of COHERE® interbody in XLIF® procedure as new clinical study further validates important benefits of Porous PEEK™ material technology

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BXMT, CHK, CHMI, CWEN, CWEN.A, EBMT, EFC, HASI, HIIQ, HMST, HTBI, HY, HZNP, JTPY, KNDI, LARK, LMRK, MBI, MFNC, MFSF, PBFX, RC, TEUM, UBNK, URG Downgrades: APTV, CFBK, CNFR, CPLP, CVEO, HF, HNGR, HPJ, IAG, INS, LGL, MAA, MCRN, MDRX, MHH, MTLS, NFBK, NUVA, OFED, OMI, VTSI, WNC, WSTL Initiations: I, ONS Read on to get TheStreet Quant Ratings' detailed report:

NuVasive Reports Third Quarter 2018 Financial Results

NuVasive Reports Third Quarter 2018 Financial Results

SAN DIEGO, Oct. 30, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive Announces Conference Call And Webcast Of Third Quarter 2018 Results

NuVasive Announces Conference Call And Webcast Of Third Quarter 2018 Results

SAN DIEGO, Oct. 11, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive Announces Strategic Partnership With Biedermann Technologies To Access Intellectual Property And Co-Develop State-of-the-Art Complex Spine Solutions

NuVasive Announces Strategic Partnership With Biedermann Technologies To Access Intellectual Property And Co-Develop State-of-the-Art Complex Spine Solutions

Biedermann Technologies' leading innovations to be available with NuVasive's RELINE® posterior fixation system to create differentiated adult and pediatric technology solutions

NuVasive Clinical Services Awarded Sole Source Intraoperative Neuromonitoring Services Contract With Premier

NuVasive Clinical Services Awarded Sole Source Intraoperative Neuromonitoring Services Contract With Premier

SAN DIEGO, Oct. 8, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive To Showcase Comprehensive Solutions For Complex Spinal Deformities At Scoliosis Research Society Annual Meeting

NuVasive To Showcase Comprehensive Solutions For Complex Spinal Deformities At Scoliosis Research Society Annual Meeting

New technologies launched to expand deformity portfolio to address additional pediatric and adult patients' clinical needs

NuVasive To Demonstrate Pulse™ Surgical Automation Platform At NASS 2018 Annual Meeting

NuVasive To Demonstrate Pulse™ Surgical Automation Platform At NASS 2018 Annual Meeting

Initial Pulse Alpha Trial Results Show Extensive Clinical Utility in Nearly all Spine Surgery Cases and Workflow Efficiencies Intended to Reduce Operating Room Time for Surgeon and Patient

NuVasive Expands Biologics Portfolio To Meet Clinical And Economic Needs

NuVasive Expands Biologics Portfolio To Meet Clinical And Economic Needs

SAN DIEGO, Sept. 24, 2018 /PRNewswire/ -- NuVasive, Inc.

Scott Huennekens To Join NuVasive Board Of Directors

Scott Huennekens To Join NuVasive Board Of Directors

New board appointment brings expertise in surgical robotics, data analytics and medical device commercialization

NuVasive To Showcase Spine Precision Surgery Leading To Smarter, More Predictable Clinical Outcomes At NASS 2018

NuVasive To Showcase Spine Precision Surgery Leading To Smarter, More Predictable Clinical Outcomes At NASS 2018

SAN DIEGO, Sept. 20, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive To Present At The Morgan Stanley 16th Annual Global Healthcare Conference

NuVasive To Present At The Morgan Stanley 16th Annual Global Healthcare Conference

SAN DIEGO, Sept. 6, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive Grows Expandable Spinal Interbody Portfolio With Launch Of TLX® 20 Degree Implant

NuVasive Grows Expandable Spinal Interbody Portfolio With Launch Of TLX® 20 Degree Implant

SAN DIEGO, Sept. 5, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At SMISS Annual Forum

NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At SMISS Annual Forum

SAN DIEGO, Sept. 4, 2018 /PRNewswire/ -- NuVasive, Inc.

NuVasive Appoints Dale Wolf To Lead Ohio Manufacturing Facility

NuVasive Appoints Dale Wolf To Lead Ohio Manufacturing Facility

GE Healthcare veteran joins NuVasive to further its goal of operational excellence

NuVasive And Siemens Healthineers Partner To Transform Spine Surgery

NuVasive And Siemens Healthineers Partner To Transform Spine Surgery

Spine Precision Partnership™ to advance clinical outcomes in spine procedures through the novel integration of 3D imaging, navigation and surgical automation

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CHEF, CLH, DYSL, FLR, FORM, GPOR, HI, IBM, KBR, KW, NUVA, TGE, WSTL, X Downgrades: EMKR, PSMT, SEB Initiations: APPN, APRN, GDI Read on to get TheStreet Quant Ratings' detailed report:

NuVasive Announces Second Quarter 2018 Financial Results

NuVasive Announces Second Quarter 2018 Financial Results

SAN DIEGO, July 31, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced financial results for...

NuVasive Unveils Spine's First Integrated Surgical Automation Platform

NuVasive Unveils Spine's First Integrated Surgical Automation Platform

Pulse™ platform receives 510(k) clearance addressing spine technology and clinical requirements across all spine procedures

Nuvasive Launches MAGEC X For Early Onset Scoliosis Treatment

Nuvasive Launches MAGEC X For Early Onset Scoliosis Treatment

The latest advancement of MAGEC® delivers improved rod strength together with internal rod mechanism advancements

NuVasive Portfolio Introduces Low-Profile Modular Implants For Posterior Fixation

NuVasive Portfolio Introduces Low-Profile Modular Implants For Posterior Fixation

The launch of Reline® MAS® Midline delivers procedural versatility in a compact midline construct

NuVasive Announces Conference Call And Webcast Of Second Quarter 2018 Results

NuVasive Announces Conference Call And Webcast Of Second Quarter 2018 Results

SAN DIEGO, July 11, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company will release...

NuVasive Unveils Newest Addition To Lateral Procedural Solutions At IMAST 2018

NuVasive Unveils Newest Addition To Lateral Procedural Solutions At IMAST 2018

XLX™ ACR® receives FDA 510(k) clearance and broadens expandable portfolio to include lateral procedures

TheStreet Quant Rating: C+ (Hold)